| 294 | 2 | 79 |
| 下载次数 | 被引频次 | 阅读次数 |
徐力教授认为肺结节内因为素体先天不足或后天失养,致肺气虚耗、脾气亏损、肝气不足或元气不充;外因为六淫、烟毒、雾霾乘虚而入,以致气郁、痰凝、血瘀、毒结,于肺络最虚处发为积聚。治疗上,徐教授以“三段”区分治法:攻毒散结期以攻伐为主,佐以扶正;扶正祛邪期虚实兼顾,攻补兼施;术后防复期调整偏颇体质,防止病情恶化及复发。在此基础上,结合“六辨”,辨肺积病位、病理类型、指标水平、病机特点、证候虚实、兼夹症状,灵活用药,达到辨病与辨证相结合。附验案1则。
Abstract:Professor XU Li believes that the endopathic causes of pulmonary nodule is innate deficiency or loss of acquired nutrients resulting in depletion of lung qi,consumption of spleen qi,deficiency of liver qi,or insufficiency of original qi,and the external causes are six exogenous factors,smoke toxicity,and haze invading the body and leading to qi stagnation,phlegm coagulation,blood stasis,and toxin accumulation,then generating the mass in the most deficient areas of the lung collaterals. In terms of treatment,Professor XU distinguishes the treatment methods by “three stages”. In the stage of removing toxin and dissipating mass,the treatment is focused on attacking pathogenic factors,supplemented by strengthening healthy qi. In the stage of reinforcing healthy qi and eliminating pathogen,both deficiency and excess should be taken into account,and treatment with both tonification and elimination should be applied. In the postoperative stage for preventing relapse,the biased constitution should be regulated to prevent the deterioration and recurrence of the disease. Based on this,the “six differentiations”(differentiating disease locations,differentiating pathological types,differentiating level of indicators,differentiating characteristics of pathogenesis,differentiating deficiency or excess of syndromes,and differentiating concurrent symptoms) should be applied to guide the flexible medication and to achieve the combination of disease differentiation and syndrome differentiation. A proved case is listed.
[1] GOULD M K,DONINGTON J,LYNCH W R,et al. Evaluation of individuals with pulmonary nodules:when is it lung cancer?[J]. Chest,2013,143(5):e93S-e120S.
[2] ZENG H,ZHENG R,GUO Y,et al. Cancer survival in China, 2003-2005:a population-based study[J]. Int J Cancer,2015,136(8):1921-1930.
[3]陆王娟.肺结节患者中医体质类型分布的初步研究[D].南京:南京中医药大学,2018.
[4]夏晓旦,黄婷,薛嫚,等.木芙蓉化学成分与药理作用的研究进展[J].中成药,2017,39(11):2356-2360.
[5]郑鑫,温静,李文兰,等.中华卷柏的化学成分和药理作用研究进展[J].国际药学研究杂志,2020,47(9):698-702,708.
[6]苗耀东,李小江,贾英杰.猫爪草的化学成分及药理作用研究进展[J].中草药,2014,45(11):1651-1654.
[7]赫军,李栋,马秉智,等.藤梨根化学成分和抗肿瘤药理作用研究进展[J].中国实验方剂学杂志,2015,21(4):213-218.
[8]窦郁,卢星如,马娴,等.孤立性肺实性结节和混杂磨玻璃结节对比研究[J].中国临床解剖学杂志,2018,36(6):657-661.
[9]王俊,曾庆华,李永红,等. CT影像学检查对肺部磨玻璃样小结节样良、恶性的鉴别诊断价值及影响因素分析[J].中国CT和MRI杂志,2021,19(6):62-64.
[10]赵会军,范薇,湛东伟,等.肺磨玻璃结节的CT征象与组织学类型相关性分析[J].北京医学,2021,43(4):321-325.
[11]赵娇,李建华,费佳,等.肺磨玻璃样结节:有助于预判肺腺癌浸润性的CT征象[J].放射学实践,2018,33(4):383-388.
[12]金艳凤,黄琴,魏中华,等.孤立性部分实性肺结节28例影像学与临床病理分析[J].临床与实验病理学杂志,2019,35(4):459-461.
[13]杨进翔.徐力教授应用三段六辨论辨治非小细胞肺癌经验研究[D].南京:南京中医药大学,2018.
[14]徐力,鹿竞文.试谈“三段六辨”抗癌模式[J].新中医,2012,44(12):157-158.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2023.11.014
中图分类号:R249;R259
引用信息:
[1]刘颖,徐力.徐力基于“三段六辨”模式治疗肺结节经验[J].山东中医杂志,2023,42(11):1211-1214+1229.DOI:10.16295/j.cnki.0257-358x.2023.11.014.
基金信息:
江苏省研究生科研创新项目(编号:SJCX21_0720); 江苏省科技支撑计划社会发展项目(编号:BE2015691)
2023-11-05
2023-11-05